TOIPF yields 2.46% · PFE yields 6.13%● Live data
📍 TOIPF pulled ahead of the other in Year 1
Combined, TOIPF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TOIPF + PFE for your $10,000?
Thai Oil Public Company Limited, together with its subsidiaries, engages in the oil refining and distribution, petrochemicals, lube base oil, and other businesses in Thailand and internationally. It operates through Oil Refinery, Lube Base Oil Refinery, Petrochemical, Power Generation, Marine Transportation Services, Solvent, Ethanol, and Others segments. The company produces gasoline, diesel/gas oil, jet fuel, kerosene, fuel oil, and liquefied petroleum gas; and petrochemical products, such as paraxylene, benzene, toluene, and mixed xylenes. It also produces and distributes lube base oil, bitumen/asphalt, and other by-products, as well as special products, such as treated distillate aromatics extract and slack wax; and hydrocarbon and chemical solvents, and other chemicals. In addition, the company operates natural gas-fired combined-cycle co-generation power plants that generate and sell electricity, steam, and utilities to industrial users, as well as invests in other power generating companies and related business. Further, it is involved in the marine transportation of petroleum, petrochemical, and liquid chemical products; production of ethanol; provision of marine transportation services for crew and utilities; and biogas power generation and distribution. Additionally, the company provides human resource management services; and manufactures and sells linear alkyl benzene and related products. Thai Oil Public Company Limited was founded in 1961 and is headquartered in Bangkok, Thailand.
Full TOIPF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.